PL3383851T3 - Pochodne dekstrorfanu o stłumionej nerwowej aktywności ośrodkowej - Google Patents
Pochodne dekstrorfanu o stłumionej nerwowej aktywności ośrodkowejInfo
- Publication number
- PL3383851T3 PL3383851T3 PL16805448T PL16805448T PL3383851T3 PL 3383851 T3 PL3383851 T3 PL 3383851T3 PL 16805448 T PL16805448 T PL 16805448T PL 16805448 T PL16805448 T PL 16805448T PL 3383851 T3 PL3383851 T3 PL 3383851T3
- Authority
- PL
- Poland
- Prior art keywords
- dextrorphan
- derivatives
- central nervous
- nervous activity
- suppressed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15197832 | 2015-12-03 | ||
| PCT/EP2016/079645 WO2017093519A1 (en) | 2015-12-03 | 2016-12-02 | Dextrorphan-derivatives with suppressed central nervous activity |
| EP16805448.4A EP3383851B1 (en) | 2015-12-03 | 2016-12-02 | Dextrorphan-derivatives with suppressed central nervous activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3383851T3 true PL3383851T3 (pl) | 2022-01-10 |
Family
ID=54782566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16805448T PL3383851T3 (pl) | 2015-12-03 | 2016-12-02 | Pochodne dekstrorfanu o stłumionej nerwowej aktywności ośrodkowej |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10464904B2 (pl) |
| EP (1) | EP3383851B1 (pl) |
| CA (1) | CA3037766C (pl) |
| ES (1) | ES2894324T3 (pl) |
| PL (1) | PL3383851T3 (pl) |
| WO (1) | WO2017093519A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107652236A (zh) * | 2017-11-14 | 2018-02-02 | 江苏宝众宝达药业有限公司 | 一种右美沙芬杂质17‑甲基吗啡喃‑3‑醇对映异构体的制备方法 |
| WO2022235576A1 (en) * | 2021-05-03 | 2022-11-10 | Wang Michael Z | Methods and compositions for treating depression |
| CA3255072A1 (en) | 2022-03-31 | 2023-10-05 | Taros Chemicals Gmbh & Co. Kg | SYNTHESIS OF MORPHINANES WITH REDUCED HERG ACTIVITY AND MOP BONDING |
| WO2025165207A1 (ko) * | 2024-02-02 | 2025-08-07 | 단국대학교 천안캠퍼스 산학협력단 | 덱스트로메토르판을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6089474A (ja) * | 1983-10-20 | 1985-05-20 | Toyo Pharma- Kk | モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤 |
| WO2008097924A2 (en) | 2007-02-05 | 2008-08-14 | Avanir Pharmaceuticals | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders |
| US20120122848A1 (en) * | 2009-07-29 | 2012-05-17 | Green Cross Corporation | (+)-3-hydroxymorphinan derivatives as neuroprotectants |
| CN102906099A (zh) * | 2010-05-13 | 2013-01-30 | 株式会社绿十字 | 作为神经保护剂的基于(+)-3-羟基吗啡喃的多环衍生物 |
| WO2013029762A1 (en) * | 2011-08-26 | 2013-03-07 | Heinrich-Heine-Universität Düsseldorf | Morphinan-derivatives for treating diabetes and related disorders |
| US10766864B2 (en) * | 2015-05-08 | 2020-09-08 | Nektar Therapeutics | Morphinan derivatives for the treatment of neuropathic pain |
-
2016
- 2016-12-02 EP EP16805448.4A patent/EP3383851B1/en active Active
- 2016-12-02 CA CA3037766A patent/CA3037766C/en active Active
- 2016-12-02 US US15/780,850 patent/US10464904B2/en active Active
- 2016-12-02 PL PL16805448T patent/PL3383851T3/pl unknown
- 2016-12-02 WO PCT/EP2016/079645 patent/WO2017093519A1/en not_active Ceased
- 2016-12-02 ES ES16805448T patent/ES2894324T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3383851B1 (en) | 2021-07-14 |
| ES2894324T3 (es) | 2022-02-14 |
| US20180362469A1 (en) | 2018-12-20 |
| WO2017093519A1 (en) | 2017-06-08 |
| CA3037766A1 (en) | 2017-06-08 |
| EP3383851A1 (en) | 2018-10-10 |
| CA3037766C (en) | 2023-09-26 |
| US10464904B2 (en) | 2019-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201704562B (en) | Picolinamides with fungicidal activity | |
| ZA201802081B (en) | Measuring multiple carriers under discontinuous activity | |
| IL256625A (en) | Antibodies to cd40 with increased agonistic activity | |
| IL250320B (en) | Compounds active toward bromodomains | |
| GB2530726B (en) | Distributed single sign-on | |
| IL247935A0 (en) | Automatic injector with shock reduction elements | |
| GB2537441B (en) | Needle assemblies | |
| GB201407288D0 (en) | Activity monitors | |
| PL3292145T3 (pl) | Mutanty fc ze zmodyfikowaną aktywnością funkcjonalną | |
| IL249511A0 (en) | Novel p450-bm3 variants with enhanced activity | |
| GB2538043B (en) | Activity monitor | |
| IL256441B (en) | New p450–bm3 variants with enhanced activity | |
| ZA201705537B (en) | Compounds with anti-tumoral activity | |
| PL3383851T3 (pl) | Pochodne dekstrorfanu o stłumionej nerwowej aktywności ośrodkowej | |
| EP3279323A4 (en) | Amadoriase having improved specific activity | |
| GB201510359D0 (en) | Incubator | |
| IL257971A (en) | Materials with combined activity | |
| GB201519799D0 (en) | Catalysts | |
| GB201517650D0 (en) | Catalysts | |
| GB201505556D0 (en) | Catalysts | |
| PT3355744T (pt) | Cama com fundo melhorado | |
| GB201517648D0 (en) | Catalysts | |
| PL3070078T3 (pl) | Niesymetryczne bisakrydyny o działaniu przeciwnowotworowym i ich zastosowania | |
| ZA201705324B (en) | Carbon activity analyser | |
| GB201510017D0 (en) | Activity assay |